Senti Biosciences, Inc.SNTINASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank58
3Y CAGR+1.7%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
+1.7%/yr
Quarterly compound
Percentile
P58
Within normal range
vs 3Y Ago
1.1x
Modest growth
Streak
1 qtr
Consecutive growthDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 38.75% |
| Q2 2025 | 0.00% |
| Q1 2025 | 100.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 100.00% |
| Q2 2024 | -0.41% |
| Q1 2024 | 0.88% |
| Q4 2023 | -678.04% |
| Q3 2023 | 193.07% |
| Q2 2023 | -176.75% |
| Q1 2023 | 286.91% |
| Q4 2022 | -112.60% |
| Q3 2022 | 36.82% |
| Q2 2022 | 1078.72% |
| Q1 2022 | 139.00% |
| Q4 2021 | -126.03% |
| Q3 2021 | 664.63% |
| Q2 2021 | 0.00% |
| Q1 2021 | 100.00% |
| Q4 2020 | 0.00% |